UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of April 2016

Commission File Number 001-37626

 

 

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

 

 

Not Applicable

(Translation of Registrant’s name into English)

Australia

(Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  x             Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes  ¨            No   x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes  ¨            No   x

 

 

 

---

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On April 19, 2016, Mesoblast Limited filed with the Australian Securities Exchange an announcement regarding the release of shares from voluntary escrow, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

 

Dated: April 22, 2016

---

INDEX TO EXHIBITS

 

Item
99.1		Release of shares from voluntary escrow, dated April 19, 2016.

Exhibit 99.1

 

				Mesoblast Limited ABN 68 109 431 870
19 April 2016				Corporate Headquarters Level 38 55 Collins Street Melbourne, Victoria 3000 AUSTRALIA   T +61 3 9639 6036 F +61 3 9639 6030
Manager Market Announcements Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000				United States Operations 505 Fifth Avenue Third Floor New York, NY 10017 USA   T +1 212 880 2060 F +1 212 880 2061   Asia 20 Biopolis Way #05-01 Centros Biopreneur 3 SINGAPORE 138668   T +65 6570 0635 F +65 6570 0176
Dear Sir or Madam				info@mesoblast.com www.mesoblast.com

Release of shares from voluntary escrow

Mesoblast Limited (ASX Code: MSB) gives notice in accordance with ASX Listing Rule 3.10A that 15,298,837 ordinary shares, which are subject to voluntary escrow arrangements, will be released from escrow on 5 May 2016.

Yours sincerely

/s/ Charlie Harrison

Charlie Harrison

Senior Legal Counsel and Company Secretary